• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AI vs. Humans: AI Solution Beats Stanford Radiologists in Chest X-ray Diagnostics Competition

by Jasmine Pennic 08/22/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

AI vs. Humans: AI Solution Beats Stanford Radiologists in Chest X-ray Diagnostics Competition

JF Healthcare, a Nanchang, China-based medical diagnostic startup is the first organization in the world to beat Stanford University radiologists in a competition designed by the Stanford Machine Learning group to compare the capability of artificial intelligence (AI) to human experts in interpreting chest x-rays.

Standard Chest X-ray Diagnostic Competition Results

AI vs. Humans: AI Solution Beats Stanford Radiologists in Chest X-ray Diagnostics Competition

The AI team from JF Healthcare recently achieved an average AUC score (a measure of diagnostic accuracy) of 0.926 and is currently ranked No. 1 in the world on Stanford’s CheXpert leaderboard. Significantly, the JF team outperforms all three Stanford radiologists on the test set, demonstrating the role that AI can play in providing precise medical diagnostics, especially in underserved areas of the world, with profound implications for the treatment of lung cancer, tuberculosis and other diseases of the thorax.

JF Healthcare Background

Founded in 2015 by former Siemens healthcare executive Frank Wu, JF offers remote diagnostic services, focusing on chest x-rays, for rural township hospitals in China where certified radiologists are often not available.  Its mobile screening truck is expected to screen more than ten provinces in China for tuberculosis by the end of 2019, offering a half-million people the possibility of early detection while preventing the spread of disease to broader populations.

JF plans to develop a chest x-ray screening product to simultaneously screen for tuberculosis, lung cancer, and pneumonia, covering the major thorax diseases based on more than 300,000 chest x-ray images with curated radiology reports collected from approximately 1,000 township hospitals. The team is hoping to fully leverage the clinical value of chest x-rays through AI and deliver it to the massive township hospital patient population in China where radiologists are most needed.

Why It Matters

“The goal is to be better than the best human in making diagnoses and deliver low-cost care with a level of quality that is equivalent to the best hospitals in the world. To do that, the secret is not math; it’s a huge volume of well-curated data,” said Wu, JF Healthcare’s Founder and CEO. “There are 3 billion people in the world without access to quality healthcare. The first step in remedying this problem is providing extremely accurate diagnostics, which is at the core of our strategy and mission.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Artificial Intelligence, cancer, lung, Lung Cancer, Machine Learning, patient population, pneumonia, Radiologist, radiology, Siemens, Stanford Health Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |